Breaking News Instant updates and real-time market news.

MRK

Merck

$73.32 /

-0.57 (-0.77%)

18:17
12/03/21
12/03
18:17
12/03/21
18:17

FDA approves Merck's KEYTRUDA for adjuvant treatment of stage IIB, IIC melanoma

Merck announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric patients with stage IIB or IIC melanoma following complete resection. Additionally, the FDA expanded the indication for KEYTRUDA as adjuvant treatment for stage III melanoma following complete resection to include pediatric patients. The approval in stage IIB and IIC melanoma is based on data from the first interim analysis of the Phase 3 KEYNOTE-716 trial, in which KEYTRUDA showed a statistically significant improvement in recurrence-free survival (RFS), reducing the risk of disease recurrence or death by 35% compared to placebo. Median RFS was not reached for either group. After a median follow-up of 14.4 months, 11% of patients who received KEYTRUDA had recurrence or died compared to 17% of patients who received placebo. Efficacy in pediatric patients with stage IIB, IIC and III melanoma is supported by extrapolation of efficacy data from adults, given similar biology, pharmacology of drug effect, as well as similar exposure-response for efficacy and safety.

  • 03

    Dec

  • 04

    Dec

  • 07

    Dec

  • 08

    Dec

  • 10

    Dec

  • 21

    Dec

  • 03

    Feb

  • 21

    Mar

  • 28

    Mar

  • 01

    Apr

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Cellnex Telecom price target lowered to EUR 65 from EUR 67 at Barclays » 15:18
01/20/22
01/20
15:18
01/20/22
15:18
CLLNY

Cellnex Telecom

$24.09 /

+0.22 (+0.92%)

Barclays analyst Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLNY Cellnex Telecom
$24.09 /

+0.22 (+0.92%)

09/27/21 Citi
Cellnex Telecom downgraded to Sell from Neutral at Citi
09/20/21 Credit Suisse
Cellnex Telecom price target raised to EUR 70 from EUR 65.76 at Credit Suisse
09/20/21 RBC Capital
Cellnex Telecom initiated with an Outperform at RBC Capital
09/09/21 JPMorgan
Cellnex Telecom price target raised to EUR 76 from EUR 72 at JPMorgan
Recommendations
Beazley price target raised to 531 GBp from 462 GBp at Barclays » 15:17
01/20/22
01/20
15:17
01/20/22
15:17
BZLYF

Beazley

$6.37 /

+ (+0.00%)

Barclays analyst Ivan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BZLYF Beazley
$6.37 /

+ (+0.00%)

BZLYF Beazley
$6.37 /

+ (+0.00%)

11/09/21 Berenberg
Beazley price target raised to 490 GBp from 460 GBp at Berenberg
11/08/21 Citi
Beazley price target raised by 8% to 495 GBp at Citi
09/13/21 Barclays
Beazley price target raised to 429 GBp from 387 GBp at Barclays
08/25/21 Goldman Sachs
Beazley initiated with a Buy at Goldman Sachs
Periodicals
Carlyle Group mulls sale of Titan acquisition, Bloomberg reports » 15:16
01/20/22
01/20
15:16
01/20/22
15:16
CG

Carlyle Group

$51.64 /

+1.05 (+2.08%)

Carlyle Group is mulling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

12/17/21 Deutsche Bank
Carlyle Group price target raised to $72 from $70 at Deutsche Bank
12/16/21 BofA
Carlyle Group initiated with a Buy at BofA
12/16/21 BofA
Carlyle Group initiated with a Buy at BofA
11/02/21 Citi
Carlyle Group price target raised to $73 from $66 at Citi
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

  • 10
    Nov
  • 19
    May
  • 12
    Mar
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

Recommendations
ASML price target raised to EUR 900 from EUR 800 at Barclays » 15:16
01/20/22
01/20
15:16
01/20/22
15:16
ASML

ASML

$719.87 /

+20.34 (+2.91%)

Barclays analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$719.87 /

+20.34 (+2.91%)

ASML ASML
$719.87 /

+20.34 (+2.91%)

15:09 Today UBS
ASML price target lowered to EUR 685 from EUR 720 at UBS
01/19/22 Summit Insights
ASML secular growth story remains intact, says Summit Insights
01/13/22 Credit Suisse
ASML resumed with an Outperform at Credit Suisse
12/20/21 Morgan Stanley
ASML initiated with an Overweight at Morgan Stanley
ASML ASML
$719.87 /

+20.34 (+2.91%)

Recommendations
Richemont price target raised to CHF 184 from CHF 169 at UBS » 15:13
01/20/22
01/20
15:13
01/20/22
15:13
CFRUY

Richemont

$15.37 /

+0.78 (+5.35%)

UBS analyst Zuzanna Pusz…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFRUY Richemont
$15.37 /

+0.78 (+5.35%)

01/18/22 Morgan Stanley
Richemont price target raised to CHF 165 from CHF 152 at Morgan Stanley
01/04/22 Barclays
Richemont price target raised to CHF 155 from CHF 150 at Barclays
12/21/21 Bryan Garnier
Richemont upgraded to Buy from Neutral at Bryan Garnier
11/17/21 Stifel
Richemont upgraded to Buy from Hold at Stifel
CFRUY Richemont
$15.37 /

+0.78 (+5.35%)

Recommendations
DCC plc price target raised to 7,900 GBp from 7,700 GBp at UBS » 15:12
01/20/22
01/20
15:12
01/20/22
15:12
DCCPY

DCC plc

$40.75 /

+ (+0.00%)

UBS analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Burberry price target raised to 1,928 GBp from 1,855 GBp at UBS » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
BURBY

Burberry

$25.39 /

+1.25 (+5.18%)

UBS analyst Zuzanna Pusz…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURBY Burberry
$25.39 /

+1.25 (+5.18%)

05:33 Today Kepler Cheuvreux
Burberry upgraded to Buy from Hold at Kepler Cheuvreux
12/20/21 Morgan Stanley
Burberry price target lowered to 1,900 GBp from 2,000 GBp at Morgan Stanley
11/15/21 UBS
Burberry price target raised to 1,845 GBp from 1,800 GBp at UBS
11/12/21 RBC Capital
Burberry price target raised to 1,980 GBp from 1,950 GBp at RBC Capital
Periodicals
Xilinx-AMD deal on course for approval from China's SAMR, Dealreporter says » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
XLNX

Xilinx

$190.00 /

+0.97 (+0.51%)

, AMD

AMD

$126.11 /

-2.18 (-1.70%)

AMD's (AMD) proposed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

12/15/21 Deutsche Bank
Xilinx price target raised to $207 from $195 at Deutsche Bank
10/28/21 Truist
Xilinx price target raised to $180 from $143 at Truist
10/28/21 Wells Fargo
Xilinx price target raised to $190 from $140 at Wells Fargo
10/28/21 Deutsche Bank
Xilinx price target raised to $195 from $155 at Deutsche Bank
AMD AMD
$126.11 /

-2.18 (-1.70%)

04:47 Today Piper Sandler
AMD downgraded to Neutral from Overweight at Piper Sandler
01/18/22 Cowen
AMD price target raised to $150 from $145 at Cowen
01/13/22 Mizuho
AMD price target raised to $150 from $135 at Mizuho
01/12/22 Barclays
AMD price target raised to $148 from $135 at Barclays
XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

Recommendations
British American Tobacco price target lowered to 3,600 GBp at UBS » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
BTI

British American Tobacco

$42.76 /

-0.1 (-0.23%)

UBS analyst Nik Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

01/18/22 Stifel
Stifel says IQOS patent win a 'positive' development for Philip Morris, Altria
01/10/22 Barclays
British American Tobacco price target raised to 3,400 GBp at Barclays
12/20/21 Citi
Citi opens 'Positive Catalyst Watch' on British American Tobacco shares
12/08/21 UBS
British American Tobacco price target raised to 3,700 GBp from 3,500 GBp at UBS
BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

Options
Peoples United Financial options imply 3.1% move in share price post-earnings » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
PBCT

People's United

$19.55 /

-0.795 (-3.91%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBCT People's United
$19.55 /

-0.795 (-3.91%)

PBCT People's United
$19.55 /

-0.795 (-3.91%)

07/22/21 Wedbush
M&T Bank price target lowered to $158 from $171 at Wedbush
05/18/21 Compass Point
People's United price target raised to $19.50 from $18.50 at Compass Point
05/10/21 Stephens
Dime Community upgraded to Overweight at Stephens following 'solid' Q1
04/06/21 Seaport Global
People's United downgraded on pending buyout at Seaport Global
PBCT People's United
$19.55 /

-0.795 (-3.91%)

Recommendations
ASML price target lowered to EUR 685 from EUR 720 at UBS » 15:09
01/20/22
01/20
15:09
01/20/22
15:09
ASML

ASML

$718.88 /

+19.35 (+2.77%)

UBS analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$718.88 /

+19.35 (+2.77%)

ASML ASML
$718.88 /

+19.35 (+2.77%)

01/19/22 Summit Insights
ASML secular growth story remains intact, says Summit Insights
01/13/22 Credit Suisse
ASML resumed with an Outperform at Credit Suisse
12/20/21 Morgan Stanley
ASML initiated with an Overweight at Morgan Stanley
10/21/21 UBS
ASML price target lowered to EUR 720 from EUR 740 at UBS
ASML ASML
$718.88 /

+19.35 (+2.77%)

Recommendations
Britvic price target lowered to 885 GBp from 945 GBp at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
BTVCY

Britvic

$25.31 /

+0.012 (+0.05%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTVCY Britvic
$25.31 /

+0.012 (+0.05%)

01/18/22 Deutsche Bank
Britvic price target raised to 945 GBp from 940 GBp at Deutsche Bank
12/13/21 Barclays
Britvic initiated with an Equal Weight at Barclays
11/30/21 RBC Capital
Britvic price target raised to 890 GBp from 870 GBp at RBC Capital
11/26/21 JPMorgan
Britvic price target raised to 1,120 GBp from 1,075 GBp at JPMorgan
Recommendations
Elior Group price target lowered to EUR 8.10 from EUR 8.50 at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
ELROF

Elior Group

$6.95 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
$6.95 /

+ (+0.00%)

11/26/21 Citi
Elior Group price target raised to EUR 9 from EUR 8 at Citi
11/01/21 Goldman Sachs
Elior Group downgraded to Neutral from Buy at Goldman Sachs
10/25/21 UBS
Elior Group price target raised to EUR 6.50 from EUR 6 at UBS
10/13/21 Deutsche Bank
Elior Group price target raised to EUR 8.50 from EUR 7 at Deutsche Bank
Recommendations
Edenred price target lowered to EUR 51.50 from EUR 53.50 at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
EDNMY

Edenred

$23.26 /

+0.06 (+0.26%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNMY Edenred
$23.26 /

+0.06 (+0.26%)

15:07 Today Deutsche Bank
Edenred price target lowered to EUR 8.10 from EUR 8.50 at Deutsche Bank
01/18/22 Berenberg
Edenred price target raised to EUR 35 from EUR 30 at Berenberg
10/06/21 HSBC
Edenred upgraded to Buy from Hold at HSBC
07/28/21 Morgan Stanley
Edenred price target raised to EUR 49 from EUR 48 at Morgan Stanley
Recommendations
Antofagasta price target lowered to 1,250 GBp from 1,280 GBp at Deutsche Bank » 15:06
01/20/22
01/20
15:06
01/20/22
15:06
ANFGF

Antofagasta

$20.32 /

+0.8347 (+4.28%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANFGF Antofagasta
$20.32 /

+0.8347 (+4.28%)

05:35 Today Liberum
Antofagasta downgraded to Sell from Hold at Liberum
01/17/22 UBS
Antofagasta upgraded to Neutral from Sell at UBS
01/14/22 Deutsche Bank
Antofagasta price target lowered to 1,280 GBp from 1,300 GBp at Deutsche Bank
01/14/22 Barclays
Antofagasta price target raised to 1,100 GBp from 1,050 GBp at Barclays
Recommendations
Credit Agricole price target raised to EUR 17 from EUR 16 at Deutsche Bank » 15:05
01/20/22
01/20
15:05
01/20/22
15:05
CRARY

Credit Agricole

$7.61 /

-0.09 (-1.17%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRARY Credit Agricole
$7.61 /

-0.09 (-1.17%)

11/12/21 Morgan Stanley
Credit Agricole price target lowered to EUR 15 from EUR 15.50 at Morgan Stanley
11/11/21 JPMorgan
Credit Agricole price target lowered to EUR 16 from EUR 17 at JPMorgan
10/18/21 Barclays
Credit Agricole price target raised to EUR 15.90 from EUR 15.50 at Barclays
09/10/21 JPMorgan
BNP Paribas downgraded to Neutral from Overweight at JPMorgan
Recommendations
Societe Generale price target raised to EUR 41 from EUR 37 at Deutsche Bank » 15:04
01/20/22
01/20
15:04
01/20/22
15:04
SCGLY

Societe Generale

$7.64 /

-0.15 (-1.93%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCGLY Societe Generale
$7.64 /

-0.15 (-1.93%)

SCGLY Societe Generale
$7.64 /

-0.15 (-1.93%)

01/07/22 Credit Suisse
Societe Generale price target raised to EUR 40 from EUR 38 at Credit Suisse
01/07/22 Morgan Stanley
Societe Generale price target raised to EUR 39 from EUR 37 at Morgan Stanley
01/06/22 JPMorgan
Societe Generale price target raised to EUR 38 from EUR 37 at JPMorgan
12/08/21 Barclays
Societe Generale upgraded to Overweight from Equal Weight at Barclays
Options
Bank OZK options imply 3.5% move in share price post-earnings » 15:04
01/20/22
01/20
15:04
01/20/22
15:04
OZK

Bank OZK

$48.09 /

-0.65 (-1.33%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

06/04/21 Wells Fargo
Bank OZK upgraded to Overweight from Equal Weight at Wells Fargo
04/14/21 Citi
Bank OZK price target raised to $40 from $37 at Citi
03/08/21 Truist
Bank OZK price target raised to $45 from $37 at Truist
01/26/21 Citi
Bank OZK price target raised to $37 from $32 at Citi
OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

Recommendations
BNP Paribas price target raised to EUR 75 from EUR 66 at Deutsche Bank » 15:03
01/20/22
01/20
15:03
01/20/22
15:03
BNPQY

BNP Paribas

$36.93 /

-0.59 (-1.57%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

01/19/22 DZ Bank
BNP Paribas upgraded to Buy from Hold at DZ Bank
01/06/22 JPMorgan
BNP Paribas price target raised to EUR 69 from EUR 63 at JPMorgan
12/21/21 Kepler Cheuvreux
BNP Paribas upgraded to Buy from Hold at Kepler Cheuvreux
12/08/21 Barclays
BNP Paribas price target raised to EUR 57.60 from EUR 52.60 at Barclays
BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

Conference/Events
Oppenheimer healthcare analysts hold an analyst/industry conference call » 15:00
01/20/22
01/20
15:00
01/20/22
15:00
ASND

Ascendis Pharma

$113.25 /

-5.42 (-4.57%)

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

01/13/22 Wedbush
Ascendis Pharma price target lowered to $186 from $191 at Wedbush
01/06/22 Cowen
Ascendis Pharma initiated with a Market Perform at Cowen
12/08/21 Wells Fargo
Ascendis Pharma initiated with an Overweight at Wells Fargo
11/19/21 Morgan Stanley
Morgan Stanley assumes Ascendis Pharma at Overweight, sees upcoming catalyst
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

  • 02
    Sep
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

Options
Altice USA put volume heavy and directionally bearish » 14:55
01/20/22
01/20
14:55
01/20/22
14:55
ATUS

Altice USA

$15.49 /

+0.035 (+0.23%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

01/18/22 Exane BNP Paribas
Altice USA downgraded yesterday to Underperform at Exane BNP Paribas
01/03/22 Wolfe Research
Altice USA cut to Peer Perform at Wolfe Research as cable's competition rises
01/03/22 Wolfe Research
Altice USA downgraded to Peer Perform from Outperform at Wolfe Research
12/15/21 Pivotal Research
Altice USA price target lowered to $22 from $30 at Pivotal Research
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

  • 24
    Aug
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

Options
SVB Capital II options imply 4.6% move in share price post-earnings » 14:49
01/20/22
01/20
14:49
01/20/22
14:49
SIVB

SVB Financial

$662.61 /

+8.62 (+1.32%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

01/13/22 Morgan Stanley
NatWest Group, SVB Financial added as top bank picks at Morgan Stanley
01/10/22 Morgan Stanley
SVB Financial assumed with an Overweight at Morgan Stanley
01/10/22 Odeon Capital
SVB Financial downgraded to Hold from Buy at Odeon Capital
01/03/22 Barclays
SVB Financial price target raised to $789 from $755 at Barclays
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

  • 10
    Aug
  • 23
    Mar
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

Options
Discovery Communications call volume above normal and directionally bullish » 14:45
01/20/22
01/20
14:45
01/20/22
14:45
DISCK

Discovery Inc.

$27.26 /

-0.52 (-1.87%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DISCK Discovery Inc.
$27.26 /

-0.52 (-1.87%)

DISCK Discovery Inc.
$27.26 /

-0.52 (-1.87%)

05/24/21 Morgan Stanley
AT&T price target lowered to $32 from $34 at Morgan Stanley
05/24/21 MoffettNathanson
MoffettNathanson downgrades Discovery to Neutral after WarnerMedia deal news
05/24/21 MoffettNathanson
Discovery downgraded to Neutral from Buy at MoffettNathanson
05/17/21 JPMorgan
JPMorgan suspends rating for AT&T after WarnerMedia, Discovery deal announcement
  • 14
    Apr
  • 24
    Feb
DISCK Discovery Inc.
$27.26 /

-0.52 (-1.87%)

DISCK Discovery Inc.
$27.26 /

-0.52 (-1.87%)

DISCK Discovery Inc.
$27.26 /

-0.52 (-1.87%)

Hot Stocks
WEC Energy raises quarterly dividend by 7.4% to 72.75c per share » 14:44
01/20/22
01/20
14:44
01/20/22
14:44
WEC

WEC Energy

$96.94 /

+0.97 (+1.01%)

The board of directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WEC WEC Energy
$96.94 /

+0.97 (+1.01%)

WEC WEC Energy
$96.94 /

+0.97 (+1.01%)

01/12/22 Goldman Sachs
WEC Energy upgraded to Neutral from Sell at Goldman Sachs
11/30/21 BMO Capital
WEC Energy initiated with a Market Perform at BMO Capital
11/03/21 Scotiabank
Scotiabank upgrades WEC after 'strong update across the board'
11/03/21 Wells Fargo
WEC Energy price target lowered to $105 from $110 at Wells Fargo
WEC WEC Energy
$96.94 /

+0.97 (+1.01%)

Hot Stocks
U.S. appeals court asks Mylan to respond to Biogen request for patent rehearing » 14:43
01/20/22
01/20
14:43
01/20/22
14:43
BIIB

Biogen

$229.15 /

-1.88 (-0.81%)

, VTRS

Viatris

$14.79 /

+0.075 (+0.51%)

The United State Court of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$229.15 /

-1.88 (-0.81%)

VTRS Viatris
$14.79 /

+0.075 (+0.51%)

BIIB Biogen
$229.15 /

-1.88 (-0.81%)

06:31 Today Barclays
Biogen price target lowered to $244 from $280 at Barclays
01/14/22 Jefferies
Biogen remains 'open to all options on the table,' says Jefferies
01/14/22 BofA
Biogen price target lowered to $245 from $275 at BofA
01/13/22 Guggenheim
Biogen downgraded to Neutral from Buy at Guggenheim
VTRS Viatris
$14.79 /

+0.075 (+0.51%)

12/09/21 Evercore ISI
Evercore 'conceptually' could understand a Viatris biosimilars deal with Biocon
06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BIIB Biogen
$229.15 /

-1.88 (-0.81%)

VTRS Viatris
$14.79 /

+0.075 (+0.51%)

BIIB Biogen
$229.15 /

-1.88 (-0.81%)

VTRS Viatris
$14.79 /

+0.075 (+0.51%)

BIIB Biogen
$229.15 /

-1.88 (-0.81%)

VTRS Viatris
$14.79 /

+0.075 (+0.51%)

BIIB Biogen
$229.15 /

-1.88 (-0.81%)

VTRS Viatris
$14.79 /

+0.075 (+0.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.